Preston H. Grantham

On the sulfate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat.

J. H. Weisburger, R. Yamamoto, Gary M. Williams et al. · PubMed · 1972 · 136 citations

Chemoprevention Strategy, Pathology, Toxicological Mechanism +18

Effect of the antioxidant butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide

Preston H. Grantham, J. H. Weisburger, Elizabeth K. Weisburger · Food and Cosmetics Toxicology · 1973 · 72 citations

Biochemistry, Medicine, Carcinogens N-2-fluorenylacetamide +8

Metabolism of the carcinogen N-hydroxy-N-2-fluorenylacetamide in germ-free rats

J. H. Weisburger, Preston H. Grantham, Richard E. Horton et al. · Biochemical Pharmacology · 1970 · 62 citations

Chemoprevention Strategy, Medicine, Toxicology +6

Phenobarbital-mediated increase in ring- and N-hydroxylation of the carcinogen N-2-fluorenylacetamide, and decrease in amounts bound to liver deoxyribonucleic acid

Taijiro Matsushima, Preston H. Grantham, Elizabeth K. Weisburger et al. · Biochemical Pharmacology · 1972 · 59 citations

Carcinogen N-2-fluorenylacetamide, Biochemistry, Oncogenic Agent +8

Participation of liver fractions and of intestinal bacteria in the metabolism of N-hydroxy-N-2-fluorenylacetamide in the rat

J.R. Williams, Preston H. Grantham, Harry H. Marsh et al. · Biochemical Pharmacology · 1970 · 59 citations

Biochemistry, Medicine, Liver Physiology +10